all report title image
  • Published On : Jul 2018
  • Code : CMI1916
  • Industry : Medical Devices
  • Pages : 200
  • Formats :

Automated Endoscopy Reprocessor Market– Automatically Disinfecting Reprocessed Endoscopes

Automated Endoscopy Reprocessors (AERs) are extensively used in healthcare settings for reprocessing of endoscopes such as duodenoscopes and endoscope accessories, to disinfect between uses. AERs disinfect reusable endoscopes by exposing their interior channels and outside surfaces to chemical solutions.

Figure 1. Global Automated Endoscopy Reprocessor Market, By Product Type, 2017

Automated Endoscopy Reprocessor  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Increasing number of gastrointestinal (GI) diseases demanding endoscopic procedures are expected to drive the automated endoscope reprocessor market growth. According to a National Institute of Health data 2014, around 20 million GI endoscopic procedures are performed annually in the U.S. Endoscopy professionals are at risk of chemicals, body fluids contamination of patients, muscle skeleton injuries, and exposure of radiation. According to International Journal of Surgery report published in 2014, the rate of contracting an infection, during a gastrointestinal endoscopic procedure is around one in 1.8 million operations. However, this infection rate may be underrated due to incomplete surveillance, asymptomatic infections, under-reporting, and infections with a long incubation period.

AERs replace few manual steps involved in endoscope reprocessing. AERs have basins to allow endoscopes to be submerged in high-level disinfection (HLD) solution. After HLD cycle, AERs automatically cleans the reprocessed endoscope with water to remove toxic HLD solution residues followed by forced air to dry the endoscope channels and prevent growth of waterborne pathogenic microorganisms during storage.

The global automated endoscopy reprocessor market size was valued at US$ 845.3 million in 2017 and is expected to witness a robust CAGR of 6.7% over the forecast period (2018–2026).

Figure 2. Global Automated Endoscopy Reprocessor Market Value (US$ Mn), by Region, 2017

Automated Endoscopy Reprocessor  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Increasing adoption of endoscope reprocessors in healthcare settings to augment the market growth

Increasing adoption rate of endoscope reprocessors in hospitals for infection prevention and control is expected to fuel the global automated endoscopy reprocessor market revenue. AERs can enhance reliability and consistency of endoscope reprocessing by standardizing several important reprocessing steps, thereby reducing the possibility of human error. The use of AERs reduces exposure of personnel to harmful chemical germicides, thereby minimizing health problems attributed to reprocessing of endoscopes.

Moreover, rising government concerns pertaining to patient safety and increasing healthcare infrastructure are factors contributing to rise in global automated endoscopy reprocessors market size. For instance, in 2015, the Centers for Disease Control and Prevention (CDC) requested the Healthcare Infection Control Practices Advisory Committee (HICPAC) to issue guidelines for improvement of facility-level training to ensure competency for endoscope reprocessing devices.

Increasing focus on product innovation is expected to support growth of the market

Various changes required in AER and endoscope design will facilitate to further reduce the risk of transmission of infections related to endoscopy. The design of flexible GI endoscopes was traditionally focused on enhanced function and performance and not on ease of cleaning and HLD. In some endoscopes such as the duodenoscope, the complex design presents a particular challenge to cleaning and HLD. The FDA has asked AER manufacturers to validate reprocessing instructions, mainly for AERs that reprocess duodenoscopes.

Several product recalls from leading manufacturers requires product upgrade and manufacturing of innovative products. For instance, in 2016, the FDA signed off on Cantel's Medivators (Advantage Plus and DSD Edge) and Steris (System 1E Liquid Chemical Sterilant Processing System) automated endoscope reprocessors that are labeled for use with duodenoscopes. In the same year, the organization also signed off on a new version of a duodenoscope from Olympus.

In addition to this, in November, 2015, the FDA ordered Custom Ultrasonics to recall all of its AERs from health care facilities due to the firm’s violations of the FD&C Act, applicable regulations, and the Consent Decree. Continuous product recalls due to stringent government regulations is expected to adversely affect the market growth, however, the opportunity to manufacture advanced products in harmony with government norms can open opportunities.

Major players operating in the global automated endoscopy reprocessor market include Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG.

Automated Endoscopy Reprocessor (AER) can enhance consistency, efficiency, and reliability of endoscope reprocessing by automating and standardizing various important reprocessing stages, eventually reducing the possibility of human error. AERs reduces exposure to harmful chemical germicides and can decrease health problems related to endoscopes reprocessing. Therefore, American Society for Gastrointestinal Endoscopy (ASGE) strongly recommends the use of AERs for endoscope reprocessing. The World Gastroenterology Organization (WGO) recommends the use of AER as the most extensive options for diagnostics improvement where sufficient resources are available. However, it also states that conversion from manual use to AERs, can generate cost and revenue offsets to produce direct financial gains for some endoscopy units in emerging economies.

Market Dynamics

Major factors driving growth of the automated endoscopy reprocessor market includes rising adoption of AERs in hospitals for infection control and prevention coupled with increasing rate of gastrointestinal disorders. According to Center for Disease Control and Prevention report of 2016, the number of adults diagnosed with ulcers were 14.7 million in the U.S. Furthermore, increasing number of endoscopy procedures and demand for minimally invasive surgeries due low hospital stay cost is also expected to fuel automated endoscope reprocessor market growth. However, risk of infection post endoscopic reprocessing procedures and complications related with AERs can negatively impact adoption of automated endoscope reprocessors, thus affecting growth of the market during the forecast period. Product recalls due to stringent government regulations is also a major factor hindering the market growth.

Key features of the study:

  • This report provides in-depth analysis of automated endoscopy reprocessor market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global automated endoscopy reprocessor market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global automated endoscopy reprocessor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the automated endoscopy reprocessor market

Detailed Segmentation:

  • Global Automated Endoscopy Reprocessor Market, By Product Type:
    • Single Basin
    • Double Basin
  • Global Automated Endoscopy Reprocessor Market, By Modality:
    • Portable
    • Standalone
  • Global Automated Endoscopy Reprocessor Market, By End User:
    • Hospital
    • Diagnostics Laboratories
    • Ambulatory Centers
  • Global Automated Endoscopy Reprocessor Market, By Geography:
    • North America
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Single Basin
        • Double Basin
      • By Modality:
        • Portable
        • Standalone
      • By End User:
        • Hospital
        • Diagnostics Laboratories
        • Ambulatory Centers
      • By Country:
        • North Africa
        • South Africa
        • Central Africa
  • Company Profiles
    • Cantel Medical Corp.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategy
    • Steris Plc.
    • Olympus Corporation
    • Johnson & Johnson
    • Steelco SpA
    • Getinge Group
    • Hoya Group
    • Metall Zug AG
    • Laboratoires Anios

*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global automated endoscopy reprocessor market is estimated to surpass US$ 2.5 Billion by 2026
Major players operating in the global automated endoscopy reprocessor market include Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG.
Among modality, standalone segment held dominant position in the automated endoscopy reprocessor market, in 2017.
Increasing number of gastrointestinal (GI) diseases demanding endoscopic procedures is one of the major factors that is expected to propel growth of the market over the forecast period.
The global automated endoscopy reprocessor market is estimated to exhibit a CAGR of 6.7% over the forecast period.
Among regions, North America holds a dominant position in the global automated endoscopy reprocessor market, owing to increase in R&D process and affordability among various organizations.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo